← Back to headlines
Wegovy Obesity Drug Remains Unreimbursed in Finland
Finland's price board has rejected a pharmaceutical company's application for basic reimbursement of the obesity drug Wegovy, meaning patients will continue to bear the full cost.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
